Aesthetic Competitors

Delisted . USA . 
Stock . Aesthetic Medical Intl
AIHDelisted Stock  USD 0.32  0.02  5.88%   
Aesthetic Medical Intl competes with Medical Facilities, Fresenius, Ramsay Health, and Nova Leap; as well as few others. The company runs under Health Care Providers & Services sector within Health Care industry. Analyzing Aesthetic Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Aesthetic Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Aesthetic Medical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.320.320.32
Details
Intrinsic
Valuation
LowRealHigh
0.300.300.35
Details
Naive
Forecast
LowNextHigh
0.390.390.39
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.290.420.56
Details

Aesthetic Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Aesthetic Medical and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Aesthetic and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Aesthetic Medical Intl does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
NVLPF
+ 0.49
JNHMF
MFCSF
+ 0.44
JNHMF
RMYHY
+ 0.39
JNHMF
NVLPF
+ 0.26
MFCSF
NVLPF
+ 0.21
RMYHY
RMYHY
+ 0.12
FSNUY
  
High negative correlations   
FSNUY
- 0.89
MFCSF
FSNUY
- 0.38
JNHMF
NVLPF
- 0.2
FSNUY
RMYHY
- 0.06
MFCSF
NVLPF
- 0.0
MCIOF
RMYHY
- 0.0
MCIOF

Risk-Adjusted Indicators

There is a big difference between Aesthetic Stock performing well and Aesthetic Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aesthetic Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Aesthetic Medical Competitive Analysis

The better you understand Aesthetic Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Aesthetic Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Aesthetic Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AIH JNHMF MFCSF MCIOF FSNUY RMYHY NVLPF
 5.88 
 0.32 
Aesthetic
 0.00 
 0.03 
Jack
 1.04 
 11.37 
Medical
 0.00 
 0.55 
MCI
 1.38 
 8.83 
Fresenius
 9.25 
 6.85 
Ramsay
 10.00 
 0.18 
Nova
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Not too volatile
Very steady
Not too volatile
Slightly risky
Out of control
Market Performance
(90 Days Performance)
Very Weak
OK
OK
Very Weak
Very Weak
Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Low
Dangerous
Low
Below Average
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Not Rated
Sell
Strong Sell
Strong Sell
Current Ratio
0.19 X
0.47 X
1.92 X
1.36 X
1.32 X
0.88 X
0.87 X
Net Asset
560.66 M
8.14 M
446.97 M
60.89 M
71.96 B
19.47 B
26.77 M
Profit Margin
(0.05) %
(0.37) %
0.02 %
(0.42) %
0.04 %
0.02 %
(0.02) %
EBITDA
25.47 M
(7.54 M)
91.86 M
(11.52 M)
2.65 B
1.51 B
3.74 M
Operating Margin
(0.11) %
(0.30) %
0.14 %
(0.40) %
0.09 %
0.03 %
(0.04) %
Current Valuation
173.12 M
6.84 M
236.98 M
50.3 M
43.74 B
17.18 B
18.18 M
Price To Book
3.27 X
4.55 X
1.31 X
4.71 X
0.71 X
3.93 X
1.12 X
Retained Earnings
(1.18 B)
N/A
N/A
N/A
N/A
1.18 B
N/A
Current Asset
287.27 M
N/A
N/A
N/A
12.51 B
1.84 B
N/A
Five Year Return
N/A
N/A
8.01 %
N/A
1.10 %
N/A
N/A
Beta
-0.2
-1.43
0.69
-0.37
1.08
0.58
0.66
Number Of Employees
1.29 K
6
24
400
319.69 K
88 K
6
Shares Outstanding
47.79 M
84.33 M
26.15 M
50.08 M
2.25 B
915.53 M
86.21 M
Cash Flow From Operations
74.29 M
(4.34 M)
75.64 M
(7.1 M)
5.08 B
715.5 M
2.18 M
Annual Yield
N/A
N/A
0.04 %
N/A
0.03 %
0.01 %
N/A
Total Debt
244.55 M
106.58 K
74.28 M
15.36 M
27.16 B
5.17 B
896.13 K
Return On Equity
-4.92
-1.78
0.22
-0.96
0.0793
0.0836
-0.0309
Z Score
N/A
32.8
1.2
1.2
N/A
1.2
10.8
Return On Asset
-0.0551
-0.33
0.0875
-0.24
0.0292
0.0155
-0.0294
Number Of Shares Shorted
294.37 K
N/A
N/A
N/A
N/A
N/A
N/A
Book Value Per Share
1.02 X
0.01 X
3.96 X
0.27 X
9.49 X
4.04 X
0.22 X
Current Liabilities
248.88 M
N/A
N/A
N/A
9.5 B
1.99 B
N/A
Total Asset
560.66 M
8.14 M
446.97 M
60.89 M
71.96 B
19.47 B
26.77 M
Debt To Equity
4.20 %
0.88 %
0.74 %
0.50 %
0.89 %
2.36 %
0.33 %
Short Ratio
0.48 X
N/A
N/A
N/A
N/A
N/A
N/A
Target Price
8.93
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
0.24
N/A
0.92
N/A
N/A
Shares Owned By Institutions
0.93 %
N/A
18.76 %
N/A
N/A
N/A
N/A
Market Capitalization
15.93 M
5.68 M
160.83 M
42.88 M
17.65 B
10.86 B
16.91 M
Price To Earning
4.53 X
N/A
20.75 X
N/A
7.33 X
48.23 X
10.57 X
Price To Earnings To Growth
N/A
N/A
N/A
N/A
1.01 X
N/A
N/A
Price To Sales
0.03 X
0.49 X
0.37 X
0.71 X
0.38 X
0.72 X
0.79 X
Net Income
(55.06 M)
(7.81 M)
15.5 M
(15.67 M)
1.82 B
274 M
1.76 M
Earnings Per Share
(0.12) X
(0.08) X
0.26 X
(0.28) X
0.77 X
0.20 X
N/A
Shares Owned By Insiders
N/A
41.27 %
0.48 %
71.63 %
N/A
N/A
36.06 %
Revenue
682.59 M
9.64 M
398.63 M
47.82 M
37.52 B
13.08 B
21.28 M
Working Capital
(299.81 M)
N/A
N/A
N/A
3.02 B
(151 M)
N/A
Cash And Equivalents
26.23 M
816.49 K
47.7 M
9.98 M
2.13 B
325.5 M
794.12 K
Cash Per Share
1.16 X
0.01 X
1.57 X
0.20 X
0.94 X
0.36 X
0.01 X
Gross Profit
355.59 M
6.66 M
148.71 M
15.01 M
10.26 B
1.41 B
7.21 M
Day Typical Price
0.33
0.033
11.4
0.55
8.81
6.85
0.18
Accumulation Distribution
0.0588
N/A
0.0113
N/A
0.0102
N/A
N/A
Market Facilitation Index
0.02
N/A
0.13
N/A
0.09
N/A
N/A
Daily Balance Of Power
(1.00)
0.0
(0.92)
0.0
1.333333
9.2 T
(9,223,372,036,855)
Period Momentum Indicator
(0.02)
N/A
(0.12)
N/A
0.12
0.58
(0.02)
Rate Of Daily Change
0.94
1.0
0.99
1.0
1.01
1.09
0.9
Day Median Price
0.33
0.033
11.42
0.55
8.8
6.85
0.18
Price Action Indicator
(0.02)
N/A
(0.11)
N/A
0.095
0.29
(0.01)
Relative Strength Index
56.55
44.02
42.42
N/A
46.94
17.84
47.97
Coefficient Of Variation
1004.56
820.47
1035.9
N/A
(1,613)
(4,148)
2020.13
Mean Deviation
16.55
4.58
1.5
N/A
0.9926
1.12
4.33
Jensen Alpha
2.61
1.88
0.189
N/A
(0.08)
(0.02)
0.1928
Total Risk Alpha
(1.73)
(0.67)
(0.15)
N/A
(0.29)
(0.54)
(0.90)
Sortino Ratio
0.104
N/A
0.0276
N/A
N/A
N/A
0.0167
Downside Variance
536.59
N/A
3.3
N/A
N/A
N/A
203.46
Standard Deviation
25.59
14.54
1.94
N/A
1.23
2.77
7.58
Kurtosis
2.98
29.72
(0.12)
N/A
(0.57)
7.52
2.66
Potential Upside
56.25
N/A
3.97
N/A
1.88
4.22
11.76
Treynor Ratio
(4.60)
(2.00)
(2.00)
N/A
1.79
0.177
0.2703
Maximum Drawdown
125.38
131.85
7.33
N/A
5.02
20.29
47.34
Variance
654.8
211.51
3.78
N/A
1.5
7.65
57.46
Market Risk Adjusted Performance
(4.59)
(1.99)
(1.99)
N/A
1.8
0.187
0.2803
Risk Adjusted Performance
0.0858
0.1026
0.0799
N/A
(0.04)
(0.01)
0.0468
Skewness
1.18
4.79
0.2837
N/A
0.2618
(0.20)
(0.19)
Semi Deviation
18.11
N/A
1.54
N/A
N/A
N/A
6.02
Information Ratio
0.0942
0.1124
0.0257
N/A
(0.17)
(0.07)
0.0313
Value At Risk
(37.88)
N/A
(2.42)
N/A
(1.95)
(4.57)
(14.29)
Expected Short fall
(22.04)
N/A
(1.78)
N/A
N/A
N/A
(9.89)
Downside Deviation
23.16
N/A
1.82
N/A
N/A
N/A
14.26
Semi Variance
327.87
N/A
2.37
N/A
N/A
N/A
36.24

Aesthetic Medical Competition Performance Charts

Five steps to successful analysis of Aesthetic Medical Competition

Aesthetic Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Aesthetic Medical Intl in relation to its competition. Aesthetic Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Aesthetic Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Aesthetic Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Aesthetic Medical Intl, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Aesthetic Medical position

In addition to having Aesthetic Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Marketing Thematic Idea Now

Marketing
Marketing Theme
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in Aesthetic Stock

If you are still planning to invest in Aesthetic Medical Intl check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aesthetic Medical's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY